Australia Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook
Australia clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)
Related Markets
Australia clinical trial biorepository & archiving solutions market highlights
- The Australia clinical trial biorepository & archiving solutions market generated a revenue of USD 70.0 million in 2023 and is expected to reach USD 179.5 million by 2030.
- The Australia market is expected to grow at a CAGR of 14.4% from 2024 to 2030.
- In terms of segment, biorepository services was the largest revenue generating service in 2023.
- Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.
Clinical trial biorepository & archiving solutions market data book summary
| Market revenue in 2023 | USD 70.0 million |
| Market revenue in 2030 | USD 179.5 million |
| Growth rate | 14.4% (CAGR from 2023 to 2030) |
| Largest segment | Biorepository services |
| Fastest growing segment | Biorepository Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biorepository Services, Archiving Solution Services |
| Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global clinical trial biorepository & archiving solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China clinical trial biorepository & archiving solutions market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 296.3 million by 2030.
Biorepository services was the largest segment with a revenue share of 66.29% in 2024. Horizon Databook has segmented the Australia clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Stringent regulatory policies related to clinical trials in Australia may hinder market growth over the forecast period. In Australia, therapeutic goods used in clinical trials are classified under therapeutic goods legislation. Clinical trial sponsors should be aware about the requirements of export, import, manufacture, and supply of therapeutic goods in Australia.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Biorepository & Archiving Solutions Market Scope
Clinical Trial Biorepository & Archiving Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)
Australia Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
